Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis

Completed · Not applicable · Has a placebo group

Conditions studied: Cystic Fibrosis Related Diabetes, Pancreatic Insufficiency

In brief

The purpose of this study is to provide the necessary data and experience to design a larger, full scale clinical trial to determine if a certain medicine (repaglinide), which increases the amount of insulin secreted by the pancreas, can improve the nutritional status and pulmonary function of adolescents and young adults with cystic fibrosis and prediabetes by improving blood glucose control. The investigators are also trying to determine the relationship between systemic inflammatory factors and glucose impairment.

Key facts

Study ID
NCT00763412
Run by
Arbelaez, Ana Maria
People needed
31
Starts
2006-11-01
Expected to finish
2013-01-01
Last updated by the study team
2017-06-05

Who can join

Age: 12 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.